CIGNA Co. (CI) Stake Lessened by Calamos Advisors LLC

Calamos Advisors LLC decreased its holdings in CIGNA Co. (NYSE:CI) by 48.9% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 22,913 shares of the health services provider’s stock after selling 21,961 shares during the period. Calamos Advisors LLC’s holdings in CIGNA were worth $3,894,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the company. Synovus Financial Corp acquired a new stake in shares of CIGNA during the 1st quarter valued at $115,000. Signaturefd LLC acquired a new stake in shares of CIGNA during the 1st quarter valued at $115,000. Elmwood Wealth Management Inc. acquired a new stake in shares of CIGNA during the 1st quarter valued at $117,000. Handelsbanken Fonder AB acquired a new stake in shares of CIGNA during the 2nd quarter valued at $214,000. Finally, Cambria Investment Management L.P. acquired a new stake in shares of CIGNA during the 1st quarter valued at $267,000. Institutional investors own 87.79% of the company’s stock.

Get CIGNA alerts:

CI has been the topic of several recent research reports. Zacks Investment Research downgraded CIGNA from a “hold” rating to a “sell” rating in a report on Wednesday, April 4th. Credit Suisse Group raised their price objective on CIGNA from $215.00 to $218.00 and gave the company an “outperform” rating in a report on Friday, May 4th. Goldman Sachs Group raised CIGNA from a “neutral” rating to a “buy” rating and raised their price objective for the company from $193.00 to $212.00 in a report on Wednesday, June 6th. Finally, ValuEngine downgraded CIGNA from a “hold” rating to a “sell” rating in a report on Monday, July 2nd. One analyst has rated the stock with a sell rating, three have issued a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $217.00.

In other CIGNA news, VP Hoeltzel Mary T. Agoglia sold 1,000 shares of CIGNA stock in a transaction dated Friday, May 25th. The stock was sold at an average price of $176.19, for a total transaction of $176,190.00. Following the transaction, the vice president now directly owns 4,635 shares of the company’s stock, valued at approximately $816,640.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William D. Zollars sold 265 shares of CIGNA stock in a transaction dated Thursday, June 14th. The stock was sold at an average price of $176.93, for a total value of $46,886.45. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by insiders.

Shares of CIGNA opened at $178.09 on Friday, according to MarketBeat.com. The stock has a market cap of $43.32 billion, a price-to-earnings ratio of 15.11, a P/E/G ratio of 1.11 and a beta of 0.62. CIGNA Co. has a 12 month low of $163.02 and a 12 month high of $227.13. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.35 and a current ratio of 0.35.

CIGNA (NYSE:CI) last announced its earnings results on Thursday, May 3rd. The health services provider reported $4.11 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.39 by $0.72. The firm had revenue of $11.38 billion for the quarter, compared to the consensus estimate of $10.97 billion. CIGNA had a return on equity of 20.90% and a net margin of 5.99%. The business’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the previous year, the business earned $2.77 EPS. equities research analysts forecast that CIGNA Co. will post 13.24 EPS for the current year.

About CIGNA

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

See Also: What does relative strength index mean?

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Head to Head Survey: Tactile Systems Technology (TCMD) and GenMark Diagnostics (GNMK)

Tactile Systems Technology (NASDAQ: TCMD) and GenMark Diagnostics (NASDAQ:GNMK) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

Profitability

Get Tactile Systems Technology alerts:

This table compares Tactile Systems Technology and GenMark Diagnostics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	6.29%	7.86%	6.56%
GenMark Diagnostics	-97.90%	-77.35%	-46.77%

Institutional & Insider Ownership

92.1% of Tactile Systems Technology shares are held by institutional investors. 8.7% of Tactile Systems Technology shares are held by insiders. Comparatively, 7.5% of GenMark Diagnostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Tactile Systems Technology and GenMark Diagnostics’ top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$109.28 million	9.19	$5.85 million	$0.21	264.76
GenMark Diagnostics	$52.52 million	7.12	-$61.85 million	($1.21)	-5.58

Tactile Systems Technology has higher revenue and earnings than GenMark Diagnostics. GenMark Diagnostics is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Tactile Systems Technology has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, GenMark Diagnostics has a beta of 0.47, suggesting that its share price is 53% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations for Tactile Systems Technology and GenMark Diagnostics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	1	2	3	0	2.33
GenMark Diagnostics	0	1	5	0	2.83

Tactile Systems Technology currently has a consensus price target of $47.88, suggesting a potential downside of 13.89%. GenMark Diagnostics has a consensus price target of $10.80, suggesting a potential upside of 60.00%. Given GenMark Diagnostics’ stronger consensus rating and higher probable upside, analysts clearly believe GenMark Diagnostics is more favorable than Tactile Systems Technology.

Summary

Tactile Systems Technology beats GenMark Diagnostics on 11 of the 14 factors compared between the two stocks.

Tactile Systems Technology Company Profile

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for the treatment of chronic diseases in the United States. The company offers proprietary Flexitouch system, an at-home solution for lymphedema patients; and ACTitouch system, a home-based solution for chronic venous insufficiency patients. It also provides Entr茅 System, a basic pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company was founded in 1995 and is headquartered in Minneapolis, Minnesota.

GenMark Diagnostics Company Profile

GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor detection technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents that enable reference laboratories and hospitals to support a range of molecular tests with a workstation and disposable test cartridges. It also provides diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, thrombophilia risk test, a warfarin sensitivity test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.

UBS Group AG Has $2.20 Million Position in New Relic Inc (NEWR)

UBS Group AG lifted its stake in shares of New Relic Inc (NYSE:NEWR) by 120.5% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 29,623 shares of the software maker’s stock after buying an additional 16,190 shares during the quarter. UBS Group AG owned 0.05% of New Relic worth $2,195,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in NEWR. California Public Employees Retirement System purchased a new stake in shares of New Relic during the 4th quarter valued at about $822,000. BlackRock Inc. raised its holdings in shares of New Relic by 4.4% during the 4th quarter. BlackRock Inc. now owns 2,215,858 shares of the software maker’s stock valued at $128,010,000 after buying an additional 94,283 shares during the period. UBS Asset Management Americas Inc. raised its holdings in shares of New Relic by 7.7% during the 4th quarter. UBS Asset Management Americas Inc. now owns 21,152 shares of the software maker’s stock valued at $1,222,000 after buying an additional 1,516 shares during the period. Geode Capital Management LLC raised its holdings in shares of New Relic by 2.9% during the 4th quarter. Geode Capital Management LLC now owns 349,177 shares of the software maker’s stock valued at $20,171,000 after buying an additional 9,930 shares during the period. Finally, Amundi Pioneer Asset Management Inc. purchased a new stake in shares of New Relic during the 4th quarter valued at about $4,246,000. Institutional investors and hedge funds own 74.08% of the company’s stock.

Get New Relic alerts:

Several equities research analysts recently commented on the company. DA Davidson assumed coverage on New Relic in a report on Wednesday, July 11th. They set a “neutral” rating and a $105.00 target price on the stock. Deutsche Bank started coverage on New Relic in a research note on Monday, June 25th. They set a “buy” rating and a $125.00 price objective for the company. Morgan Stanley raised their price objective on New Relic from $73.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, June 27th. Argus started coverage on New Relic in a research note on Tuesday. They set a “hold” rating for the company. Finally, Robert W. Baird raised their price objective on New Relic from $88.00 to $115.00 and gave the company an “outperform” rating in a research note on Tuesday, June 5th. Ten investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. New Relic presently has an average rating of “Buy” and an average price target of $91.35.

Shares of New Relic opened at $111.27 on Thursday, according to Marketbeat.com. New Relic Inc has a fifty-two week low of $42.69 and a fifty-two week high of $111.87.

New Relic (NYSE:NEWR) last issued its quarterly earnings data on Tuesday, May 8th. The software maker reported $0.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.05 by $0.04. New Relic had a negative return on equity of 20.14% and a negative net margin of 12.76%. The firm had revenue of $98.40 million during the quarter, compared to analyst estimates of $96.34 million. During the same quarter last year, the firm earned ($0.11) EPS. New Relic’s quarterly revenue was up 34.2% on a year-over-year basis. analysts anticipate that New Relic Inc will post -0.57 earnings per share for the current fiscal year.

In other news, insider James R. Gochee sold 331 shares of New Relic stock in a transaction that occurred on Monday, June 18th. The stock was sold at an average price of $109.05, for a total value of $36,095.55. Following the completion of the transaction, the insider now owns 320,252 shares in the company, valued at approximately $34,923,480.60. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider James R. Gochee sold 5,122 shares of New Relic stock in a transaction that occurred on Wednesday, May 16th. The stock was sold at an average price of $87.70, for a total value of $449,199.40. Following the completion of the transaction, the insider now owns 325,471 shares of the company’s stock, valued at approximately $28,543,806.70. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 419,609 shares of company stock valued at $39,401,786. 20.40% of the stock is owned by insiders.

New Relic Profile

New Relic, Inc, a software-as-a-service company, provides various digital products worldwide. Its cloud-based platform and suite of products include New Relic Platform, which enable organizations to collect, store, and analyze data. The company offers New Relic Application Performance Management that provides visibility into the performance and usage of server-based applications, such as data pertaining to response time, transaction throughput, error rates, top transactions, and user satisfaction; New Relic Mobile, which provides code-level visibility into the performance and health of mobile applications running on the iOS and Android mobile operating systems; and New Relic Browser that monitors the page view experiences of actual end-users for desktop and mobile browser-based applications.

Featured Article: Short Selling – Explanation For Shorting Stocks

Head-To-Head Contrast: Adecoagro (AGRO) & Alico (ALCO)

Adecoagro (NYSE: AGRO) and Alico (NASDAQ:ALCO) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

Dividends

Get Adecoagro alerts:

Alico pays an annual dividend of $0.24 per share and has a dividend yield of 0.8%. Adecoagro does not pay a dividend.

Volatility & Risk

Adecoagro has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, Alico has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500.

Earnings & Valuation

This table compares Adecoagro and Alico’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adecoagro	$933.18 million	1.09	$9.97 million	$0.08	105.00
Alico	$129.83 million	2.01	-$9.45 million	N/A	N/A

Adecoagro has higher revenue and earnings than Alico.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Adecoagro and Alico, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adecoagro	0	2	1	0	2.33
Alico	0	0	0	0	N/A

Adecoagro currently has a consensus price target of $9.00, suggesting a potential upside of 7.14%. Given Adecoagro’s higher probable upside, analysts plainly believe Adecoagro is more favorable than Alico.

Profitability

This table compares Adecoagro and Alico’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Adecoagro	1.29%	1.81%	0.71%
Alico	-9.44%	-2.23%	-0.91%

Institutional and Insider Ownership

36.1% of Adecoagro shares are held by institutional investors. Comparatively, 74.2% of Alico shares are held by institutional investors. 60.1% of Alico shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Adecoagro beats Alico on 8 of the 12 factors compared between the two stocks.

About Adecoagro

Adecoagro S.A., an agricultural company, engages in farming crops and other agricultural products, dairy operations, sugar, ethanol and energy production, and land transformation activities in South America. The company is involved in planting, harvesting, and selling grains, oilseeds, and fibers, including wheat, corn, soybeans, cotton, sunflowers, and others; and providing grain warehousing/conditioning, and handling and drying services to third parties. It also engages in planting, harvesting, processing, and marketing rice; and producing and selling fluid milk and other dairy products. In addition, the company is involved in the cultivation and processing of sugar and ethanol, as well as cogeneration of electricity from sugarcane bagasse; and identification and acquisition of underdeveloped and undermanaged farmland, and realization of value through the strategic disposition of assets. Further, it is involved in leasing approximately 27,216 hectares of pasture land to cattle farmers in Argentina; and coffee plantation in the Rio de Janeiro farm located in Western Bahia to a third party. As of December 31, 2016, the company owned a total of 246,139 hectares, which comprised 19 farms in Argentina, 11 farms in Brazil, and 1 farm in Uruguay; 3 rice processing facilities in Argentina; 2 dairy facilities with approximately 6,880 milking cows in Argentina; 11 grain and rice conditioning and storage plants in Argentina; and 3 sugar and ethanol mills in Brazil with a sugarcane crushing capacity of 11.2 million tons, as well as had a total of 232 MW of installed cogeneration capacity. Adecoagro S.A. was founded in 2002 and is based in Luxembourg.

About Alico

Alico, Inc., together with its subsidiaries, operates as an agribusiness and land management company in the United States. The company operates through three segments: Alico Citrus, Conservation and Environmental Resources, and Other Operations. The Alico Citrus segment engages in planting, owning, cultivating, and/or managing citrus groves to produce fruits for sale to fresh and processed citrus markets; and contracting for the harvesting, marketing, and hauling of citrus. The Conservation and Environmental Resources segment is involved in the activities related to cattle grazing, sod, native plant, and animal sales; and leasing, management, and/or conservation of unimproved native pasture land. The Other Operations segment engages in the activities related to rock mining royalties, oil exploration, and other lines of business; and ownership and/or lease of improved farmland. Alico, Inc. owned approximately 122,000 acres of land located in 12 counties in Florida, which include the Alachua, Charlotte, Collier, DeSoto, Glades, Hardee, Hendry, Highlands, Lee, Martin, Osceola, and Polk. The company was founded in 1960 and is based in Fort Myers, Florida. Alico, Inc. is a subsidiary of 734 Investors, LLC.

Hot Clean Energy Stocks To Watch For 2019

tags:ASTE,CYBE,MTW,WLL,NWS,TRMB,

Quick Take

Bloom Energy (BE) intends to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement.

The firm provides a new means of generating clean energy from renewable sources, delivering on-site electricity for organizations worldwide.

BE is seeking cheaper public capital as it plans to continue scaling its corporate offerings.

When we learn further details from management about IPO pricing and valuation, I��ll provide a final opinion.

Company & Technology

The Sunnyvale, California-based company was founded in 2001 to change the way the world generates and consumes energy by converting fuels into electricity, without combustion.

Hot Clean Energy Stocks To Watch For 2019: Astec Industries, Inc.(ASTE)

Advisors' Opinion:

• [By Logan Wallace]

  Dean Investment Associates LLC boosted its holdings in Astec Industries, Inc. (NASDAQ:ASTE) by 5.1% in the first quarter, HoldingsChannel.com reports. The firm owned 59,000 shares of the industrial products company’s stock after acquiring an additional 2,870 shares during the period. Dean Investment Associates LLC’s holdings in Astec Industries were worth $3,256,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

• [By Logan Wallace]

  Douglas Dynamics (NYSE: PLOW) and Astec Industries (NASDAQ:ASTE) are both small-cap auto/tires/trucks companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.

• [By Stephan Byrd]

  Shares of Astec Industries, Inc. (NASDAQ:ASTE) have earned an average recommendation of “Buy” from the nine ratings firms that are currently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $67.25.

• [By Stephan Byrd]

  Shares of Astec Industries (NASDAQ:ASTE) have received an average recommendation of “Buy” from the nine analysts that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $67.25.

Hot Clean Energy Stocks To Watch For 2019: CyberOptics Corporation(CYBE)

Advisors' Opinion:

• [By Ethan Ryder]

  Perceptron (NASDAQ: PRCP) and CyberOptics (NASDAQ:CYBE) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

Hot Clean Energy Stocks To Watch For 2019: Manitowoc Company, Inc. (MTW)

Advisors' Opinion:

• [By Joseph Griffin]

  The Manitowoc Company (NYSE:MTW) – Stock analysts at William Blair upped their Q2 2018 earnings per share estimates for The Manitowoc in a report released on Tuesday, May 8th. William Blair analyst L. De. Maria now forecasts that the industrial products company will post earnings of $0.30 per share for the quarter, up from their prior estimate of $0.18.

• [By Joseph Griffin]

  The Manitowoc Company (NYSE:MTW) shares were down 5.8% on Thursday . The stock traded as low as $24.14 and last traded at $24.49. Approximately 525,529 shares changed hands during mid-day trading, a decline of 18% from the average daily volume of 643,558 shares. The stock had previously closed at $26.01.

• [By Joseph Griffin]

  Here are some of the news headlines that may have impacted Accern Sentiment Analysis’s rankings:

  Get Manitowoc alerts: Manitowoc (MTW) Lifted to Neutral at JPMorgan Chase & Co. (americanbankingnews.com) Benzinga’s Top Upgrades, Downgrades For June 21, 2018 (benzinga.com) An Eye on P/E Ratio of The Stock �� Manitowoc Company Inc (NYSE: MTW) (stocksmarketcap.com) Review the Facts about stock: The Manitowoc Company, Inc. (MTW) (connectinginvestor.com) Manitowoc Company Inc.: New Manitowoc tower crane structure for Europe and Africa (twst.com)

  Shares of MTW stock traded up $1.01 during trading hours on Friday, reaching $27.18. The company had a trading volume of 944,608 shares, compared to its average volume of 611,803. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.69 and a quick ratio of 0.72. The firm has a market capitalization of $929.53 million, a PE ratio of -104.54 and a beta of 1.54. Manitowoc has a 12-month low of $22.12 and a 12-month high of $44.03.

• [By Neha Chamaria]

  First, cost inflation isn't a company-specific concern. Manitowoc (NYSE:MTW), for instance, pointed�out last quarter how higher material, particularly steel, and labor costs are proving to be notable headwinds, compelling the company to bank on product price increases to tide over the challenges.

• [By Logan Wallace]

  Koch Industries Inc. bought a new position in shares of Manitowoc Company Inc (NYSE:MTW) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 15,931 shares of the industrial products company’s stock, valued at approximately $453,000.

• [By Dan Caplinger]

  Wednesday was a good day on Wall Street, with the Nasdaq Composite and Russell 2000�indexes both hitting record highs and other major benchmarks also generally posting solid gains. Optimism about the strong U.S. economy was enough to offset geopolitical concerns related to trade even as White House officials reiterated their position on keeping newly imposed tariffs in place. Some individual companies also had good news that sent their shares sharply higher. Advanced Micro Devices (NASDAQ:AMD), Nektar Therapeutics (NASDAQ:NKTR), and Manitowoc (NYSE:MTW) were among the best performers on the day. Here's why they did so well.

Hot Clean Energy Stocks To Watch For 2019: Whiting Petroleum Corporation(WLL)

Advisors' Opinion:

• [By Max Byerly]

  Foundry Partners LLC acquired a new stake in Whiting Petroleum Corp (NYSE:WLL) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 108,476 shares of the oil and gas exploration company’s stock, valued at approximately $3,671,000. Foundry Partners LLC owned about 0.12% of Whiting Petroleum at the end of the most recent quarter.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Whiting Petroleum (WLL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Matthew DiLallo]

  Whiting Petroleum (NYSE:WLL) bounded upward more than 55% for the quarter, fueled by rising crude prices and its strong first-quarter results. After struggling to scrape by on lower oil prices, Whiting's cash flow has surged this year, providing it enough money to fund its drilling program with more than $100 million to spare during the first quarter.

• [By Logan Wallace]

  Penn Capital Management Co. Inc. purchased a new stake in shares of Whiting Petroleum Corp (NYSE:WLL) in the 1st quarter, HoldingsChannel reports. The fund purchased 318,157 shares of the oil and gas exploration company’s stock, valued at approximately $10,783,000.

• [By Logan Wallace]

  Shares of Whiting Petroleum Corp (NYSE:WLL) have been given an average rating of “Buy” by the thirty-two ratings firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, thirteen have given a hold recommendation, fifteen have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $46.58.

• [By Jon C. Ogg]

  Whiting Petroleum Corp. (NYSE: WLL) was reiterated as Overweight and the target price was raised to $56 from $45 (versus a $50.78 close) at KeyBanc Capital Markets.

Hot Clean Energy Stocks To Watch For 2019: News Corporation(NWS)

Advisors' Opinion:

• [By Joseph Griffin]

  New Media Inv Group (NYSE: NEWM) and News (NASDAQ:NWS) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

• [By Max Byerly]

  News articles about News Corp Class B (NASDAQ:NWS) have trended somewhat positive on Saturday, Accern Sentiment reports. The research group scores the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. News Corp Class B earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave news stories about the company an impact score of 45.8601342975312 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

• [By Joseph Griffin]

  BidaskClub cut shares of News Corp Class B (NASDAQ:NWS) from a hold rating to a sell rating in a research note issued to investors on Tuesday.

  NASDAQ NWS opened at $15.55 on Tuesday. News Corp Class B has a 52 week low of $13.10 and a 52 week high of $17.70. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.02. The stock has a market capitalization of $9.12 billion, a price-to-earnings ratio of 32.60 and a beta of 1.80.

Hot Clean Energy Stocks To Watch For 2019: Trimble Navigation Limited(TRMB)

Advisors' Opinion:

• [By Lisa Levin]

   

  Companies Reporting After The Bell Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion. International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million. Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million. General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million. Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million. Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million. Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million. National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion. The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million. Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion. Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million. AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion. Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion. Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million. Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39
• [By Ethan Ryder]

  Trimble (NASDAQ: TRMB) and Faro Technologies (NASDAQ:FARO) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

• [By Logan Wallace]

  Trimble (NASDAQ: TRMB) and Image Sensing Systems (NASDAQ:ISNS) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

• [By Shane Hupp]

  Neuberger Berman Group LLC cut its position in shares of Trimble Inc. (NASDAQ:TRMB) by 0.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 646,355 shares of the scientific and technical instruments company’s stock after selling 4,136 shares during the quarter. Neuberger Berman Group LLC’s holdings in Trimble were worth $23,200,000 at the end of the most recent reporting period.

• [By Shane Hupp]

  Trimble (NASDAQ:TRMB) was downgraded by Goldman Sachs Group from a “conviction-buy” rating to a “buy” rating in a research note issued on Wednesday, The Fly reports.

Another Analyst Is Defending Twitter's Purge

Twitter (NYSE:TWTR) kicked off the week with a precipitous plunge, following a report that the company had purged over 70 million accounts in May and June. Considering the fact that Twitter had roughly 336 million monthly active users (MAUs) in the first quarter, the figures made investors nervous that Twitter's user metrics -- which have always been a point of concern -- could take a hit when it reports second-quarter results at the end of July.

JPMorgan analyst Doug Anmuth defended the company, saying the sell-off was an overreaction. It also helped assuage investor fears when Twitter CFO Ned Segal tweeted that "most" of the removed accounts were never included in the company's user metrics due to inactivity.

If we removed 70M accounts from our reported metrics, you would hear directly from us. This article reflects us getting better at improving the health of the service. Look forward to talking more on our earnings call July 27!

�� Ned Segal (@nedsegal) July 9, 2018

Now, another Street analyst is stepping up to defend the move.

Fighting fake news

CNBC reports that Goldman Sachs analyst Heath Terry has released a research note reiterating his buy rating on Twitter shares while boosting his price target from $40 to $55, representing over 20% upside from today's close. (That's $5 higher than Anmuth's price target.) Terry believes that the purging of inactive, spammy accounts is a net positive for the overall health of the platform. Importantly, combating abuse, harassment, and spam encourages advertisers to spend more on Twitter.

Image source: Getty Images.

Twitter has been talking about its broader efforts to improve information quality, and curbing spam is a big part of that. In his opening remarks on the April earnings�call, CEO Jack Dorsey noted:

This quarter we committed to help increase the collective health, openness, and civility of public conversation on Twitter, and to hold ourselves publicly accountable toward progress. We're investing in improving the health of our service by building a framework to help encourage more healthy debate, conversations, and critical thinking. And we're soliciting external experts to help us get this right. This is a holistic approach, inclusive of our ongoing work in safety and information quality where we continue to make progress.

"Twitter continues to build on 'Information Quality' efforts they first spoke about on the fourth-quarter earnings call by moderating unwanted behavior, spam accounts, and low quality tweets through product innovation, acquisition, or more active removal of violating accounts and developer applications," Terry wrote in the research note, according to the report.

Fighting spam and abuse helps engagement

Twitter has been executing very well on its overall turnaround plan for the past several years -- including recently posting its first GAAP-profitable quarter -- and Terry doesn't believe the Street is fully appreciating that progress. Analyst consensus estimates could be underestimating the company's ability to continue bolstering engagement and monetization, in Terry's view.

There's no question that engagement continues to rise, judging by the daily active user (DAU) growth figures that Twitter often touts (but won't disclose in absolute numbers). To the extent that Twitter is successful in cleaning up its platform, that trend could be here to stay.

FINTECH ACQUISI/SH (FNTE) Receives News Impact Score of 0.10

Media coverage about FINTECH ACQUISI/SH (NASDAQ:FNTE) has trended somewhat positive this week, Accern Sentiment reports. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. FINTECH ACQUISI/SH earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned media stories about the company an impact score of 44.3252318777992 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Separately, Northland Securities assumed coverage on shares of FINTECH ACQUISI/SH in a research report on Thursday, June 7th. They issued an “outperform” rating and a $15.00 target price for the company.

Get FINTECH ACQUISI/SH alerts:

Shares of NASDAQ:FNTE traded down $0.02 on Friday, hitting $10.00. The company had a trading volume of 113,200 shares, compared to its average volume of 147,814. FINTECH ACQUISI/SH has a 1 year low of $9.70 and a 1 year high of $11.76.

In related news, Director Betsy Z. Cohen bought 500,000 shares of the company’s stock in a transaction dated Friday, June 29th. The stock was purchased at an average cost of $10.05 per share, with a total value of $5,025,000.00. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Daniel G. Cohen bought 300,000 shares of the company’s stock in a transaction dated Friday, June 29th. The stock was bought at an average cost of $10.05 per share, with a total value of $3,015,000.00. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 1,000,000 shares of company stock valued at $10,050,000.

FINTECH ACQUISI/SH Company Profile

FinTech Acquisition Corp. II intends to acquire businesses or assets through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business transaction. The company was founded in 2015 and is based in Philadelphia, Pennsylvania.

Gold prices to trade lower today: Angel Commodities

Angel Commodities' report on Gold

Spot gold prices traded higher marginally to close at $ 1257.3 per ounce as weakness in the DX coupled with ongoing trade tensions pushed the yellow metal to one week high. Despite escalating trade tensions between US and China, gold prices have been falling as markets are pricing in two more rate hikes for the rest of the year. Rising interest rate scenarios does not favour investments in the yellow metal and hence the prices correction.� The US economy growing at 4.5 annualised rate in the second quarter, and steady dollar are blend of options for gold prices to move down in the coming weeks. MCX gold prices gained 0. 1 percent to trade at Rs. 30650 per 10 gms.

Outlook
ADP Nonfarm employment change and Non - Farm payrolls data due this week will decide further course of gold prices while interest rate hikes in the US will exert downside pressure on the yellow metal. On the MCX, gold prices are expected to trade lower today, international markets are trading flat at $ 1254.8 per ounce.

click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions. Read More First Published on Jul 6, 2018 12:27 pm

Top 10 Heal Care Stocks To Buy For 2019

tags:NRE,ARCW,HCP,USAP,ECOM ,DRIO,FLIC,SHPG,SNA,CEA,

Lyft has been making headlines for all the right reasons in 2017, and the latest round of positive news is the ride-hailing service launched in Toronto, Canada, on Dec. 12, 2017.

The announcement increases the speculation Lyft is gearing up for an IPO…

Entering new markets makes Lyft a more attractive investment because it will allow the company to make more money. The more money Lyft makes, the more investors will be willing to pay for Lyft stock when the company goes public.

However, you shouldn't buy shares of Lyft just because of international expansion.

Top 10 Heal Care Stocks To Buy For 2019: NorthStar Realty Europe Corp.(NRE)

Advisors' Opinion:

• [By Joseph Griffin]

  Northstar Realty Europe Corp (NYSE:NRE) has earned an average rating of “Hold” from the six ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $16.83.

• [By Shane Hupp]

  Teachers Insurance & Annuity Association of America increased its holdings in NorthStar Realty Europe (NYSE:NRE) by 15.7% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 71,499 shares of the financial services provider’s stock after purchasing an additional 9,699 shares during the period. Teachers Insurance & Annuity Association of America owned approximately 0.13% of NorthStar Realty Europe worth $931,000 as of its most recent SEC filing.

• [By Stephan Byrd]

  NorthStar Realty Europe (NYSE:NRE) has been assigned a consensus recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $17.17.

Top 10 Heal Care Stocks To Buy For 2019: Arc Wireless Solutions Inc.(ARCW)

Advisors' Opinion:

• [By Ethan Ryder]

  Watts Water Technologies (NYSE: WTS) and ARC Group WorldWide (NASDAQ:ARCW) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

• [By Shane Hupp]

  Barnes Group (NYSE: B) and ARC Group WorldWide (NASDAQ:ARCW) are both industrial products companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

• [By Max Byerly]

  CIRCOR International (NYSE: CIR) and ARC Group WorldWide (NASDAQ:ARCW) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.

• [By Joseph Griffin]

  News articles about ARC Group WorldWide (NASDAQ:ARCW) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. ARC Group WorldWide earned a news sentiment score of 0.08 on Accern’s scale. Accern also assigned media coverage about the technology company an impact score of 45.8235732272447 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Top 10 Heal Care Stocks To Buy For 2019: HCP, Inc.(HCP)

Advisors' Opinion:

• [By Ethan Ryder]

  HCP (NYSE:HCP) was downgraded by analysts at Evercore ISI from an in-line rating to an underperform rating.

  Aurubis (ETR:NDA) was given a €90.00 ($104.65) target price by analysts at Nord/LB. The firm currently has a buy rating on the stock.

• [By Reuben Gregg Brewer]

  �An aging baby boomer population is set to boost results at HCP, Inc. (NYSE:HCP) and�Universal Health Services, Inc. (NYSE:UHS) for years to come. But is it better to own physical assets, like real estate investment trust HCP, or run them, like health facility operator Universal? In the end, these two companies are very similar but also differ in many ways. Here's what you need to know to pick the one that's right for you.

• [By Matthew Frankel]

  Healthcare real estate investment trust HCP (NYSE:HCP) hasn't exactly been a high-performing stock recently. In fact, while the S&P 500 has risen 26% over the past two years, HCP has fallen 23%.

• [By Ethan Ryder]

  HCP (NYSE:HCP) had its price objective reduced by Morgan Stanley from $28.00 to $23.50 in a research report issued to clients and investors on Thursday. The brokerage presently has an “equal weight” rating on the real estate investment trust’s stock. Morgan Stanley’s price objective indicates a potential downside of 2.16% from the stock’s current price.

• [By Nelson Hem]

  In "Raymond James Picks Welltower, Sabra Health In Underweighted Health Care REIT Sector," Shanthi Rexaline takes a look at why HCP, Inc. (NYSE: HCP) didn't make the cut among these health care REIT picks.

Top 10 Heal Care Stocks To Buy For 2019: Universal Stainless & Alloy Products, Inc.(USAP)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on Universal Stainless & Alloy Products (USAP)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Shares of Universal Stainless & Alloy Products, Inc. (NASDAQ:USAP) traded down 0% on Friday . The company traded as low as $24.22 and last traded at $24.53. 505,097 shares were traded during trading, an increase of 1,278% from the average session volume of 36,661 shares. The stock had previously closed at $24.53.

Top 10 Heal Care Stocks To Buy For 2019: ChannelAdvisor Corporation(ECOM )

Advisors' Opinion:

• [By Shane Hupp]

  ChannelAdvisor (NYSE: ECOM) and Tyler Technologies (NYSE:TYL) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.

• [By Ethan Ryder]

  B. Riley started coverage on shares of ChannelAdvisor (NYSE:ECOM) in a report published on Tuesday, MarketBeat.com reports. The firm issued a buy rating and a $17.50 price target on the software maker’s stock. B. Riley also issued estimates for ChannelAdvisor’s Q2 2018 earnings at ($0.21) EPS, Q3 2018 earnings at ($0.11) EPS, Q4 2018 earnings at $0.03 EPS, FY2018 earnings at ($0.41) EPS, Q1 2019 earnings at ($0.09) EPS, Q2 2019 earnings at ($0.11) EPS, Q3 2019 earnings at ($0.04) EPS, Q4 2019 earnings at $0.07 EPS and FY2019 earnings at ($0.16) EPS.

Top 10 Heal Care Stocks To Buy For 2019: DarioHealth Corp. (DRIO)

Advisors' Opinion:

• [By Lisa Levin]

  DarioHealth Corp. (NASDAQ: DRIO) is projected to report quarterly loss at $0.19 per share on revenue of $1.74 million.

  CPI Aerostructures, Inc. (NYSE: CVU) is estimated to report quarterly earnings at $0.1 per share on revenue of $18.50 million.

Top 10 Heal Care Stocks To Buy For 2019: The First of Long Island Corporation(FLIC)

Advisors' Opinion:

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on First of Long Island (FLIC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Buy For 2019: Shire plc(SHPG)

Advisors' Opinion:

• [By Lisa Levin]

  Breaking news

  Alcoa Corp (NYSE: AA) reported better-than-expected earnings for its first quarter and raised its FY18 adjusted EBITDA outlook. Takada offered to buy Shire plc (NASDAQ: SHPG) at £46.50 per share, Reuters reported. Danaher Corporation (NYSE: DHR) reported better-than-expected earnings for its first quarter. Bank of New York Mellon Corporation (NYSE: BK) reported upbeat earnings for its first quarter.

• [By Benzinga News Desk]

  Takeda Pharmaceutical Co. moved closer to securing a $64 billion takeover of Shire PLC (NASDAQ: SHPG) after the target said it was willing to recommend that shareholders accept the Japanese firm’s latest proposal and extended a deadline to reach a definitive agreement: Link $

• [By Todd Campbell]

  Takeda Pharmaceutical Co. (NASDAQOTH:TKPYY) announced late last month its interest in making an offer to acquire Shire (NASDAQ:SHPG), and according to Shire, Takeda has followed through with three separate bids. So far, Shire's board of directors has rejected the offers as inadequate, but that doesn't mean another offer won't convince them otherwise. It's unclear if Takeda will make yet another bid, or when it might do so. But even if it doesn't, a deal could still be struck.

• [By Money Morning News Team]

  Ireland's Shire Plc. (Nasdaq: SHPG) develops medications for rare diseases and disorders, often for tremendous profits.

  The company's ADHD treatment, Vyvanse, generated $2 billion in revenue last year while its hemophilia treatment brought in almost $3 billion in revenue. Meanwhile, the angioedema treatments brought in more than $1.4 billion.

• [By Benzinga News Desk]

  Takeda Pharmaceutical Co. on Tuesday reached an agreement to buy Shire PLC (NASDAQ: SHPG), capping a months long battle for control of the European drugmaker and marking the biggest-ever overseas acquisition by a Japanese company: Link $

• [By ]

  Allergan's (NYSE: AGN) recent decision to back out of a bidding war for Shire (Nasdaq: SHPG) gives me new confidence in the company. While the acquisition could have given Allergan a diversified rare-disease portfolio of drugs, it would have meant a debt-binging acquisition and I'm always hesitant around the 'winner' of bidding wars.

Top 10 Heal Care Stocks To Buy For 2019: Snap-On Incorporated(SNA)

Advisors' Opinion:

• [By Dan Caplinger]

  Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven't seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here's why they did so well.

• [By Shane Hupp]

  Swiss National Bank lowered its position in shares of Snap-on (NYSE:SNA) by 13.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 183,800 shares of the company’s stock after selling 29,700 shares during the quarter. Swiss National Bank owned 0.32% of Snap-on worth $27,118,000 as of its most recent filing with the SEC.

• [By Joseph Griffin]

  Earnest Partners LLC decreased its position in Snap-on Incorporated (NYSE:SNA) by 0.6% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 982,944 shares of the company’s stock after selling 5,445 shares during the quarter. Snap-on makes up 1.4% of Earnest Partners LLC’s portfolio, making the stock its 13th biggest holding. Earnest Partners LLC’s holdings in Snap-on were worth $145,024,000 at the end of the most recent quarter.

Top 10 Heal Care Stocks To Buy For 2019: China Eastern Airlines Corporation Ltd.(CEA)

Advisors' Opinion:

• [By Shane Hupp]

  China Southern Airlines (NYSE: ZNH) and China Eastern Airlines (NYSE:CEA) are both large-cap transportation companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

• [By Ethan Ryder]

  China Eastern Airlines (NYSE: CEA) is one of 24 public companies in the “Air transportation, scheduled” industry, but how does it weigh in compared to its rivals? We will compare China Eastern Airlines to similar businesses based on the strength of its earnings, dividends, analyst recommendations, institutional ownership, risk, profitability and valuation.

• [By Lisa Levin] Gainers Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday. Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast. Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading. Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion. Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading. Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday. Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading. Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday. New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results. Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid. Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading. Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday. SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year. Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday. Deutsche Bank Aktiengesellschaft (NYSE: D

IOST (IOST) Reaches 24-Hour Volume of $20.41 Million

IOST (CURRENCY:IOST) traded down 3.3% against the US dollar during the 24-hour period ending at 17:00 PM ET on July 6th. One IOST token can currently be purchased for $0.0247 or 0.00000377 BTC on exchanges including Kyber Network, Kucoin, Cobinhood and Binance. During the last week, IOST has traded 11.7% higher against the US dollar. IOST has a market capitalization of $207.73 million and $20.41 million worth of IOST was traded on exchanges in the last 24 hours.

Here is how other cryptocurrencies have performed during the last 24 hours:

Get IOST alerts: XRP (XRP) traded down 0.4% against the dollar and now trades at $0.47 or 0.00007231 BTC. Stellar (XLM) traded up 1.8% against the dollar and now trades at $0.21 or 0.00003126 BTC. IOTA (MIOTA) traded down 6.3% against the dollar and now trades at $1.06 or 0.00016159 BTC. Tether (USDT) traded down 0.1% against the dollar and now trades at $1.00 or 0.00015287 BTC. NEO (NEO) traded down 5.3% against the dollar and now trades at $37.78 or 0.00575165 BTC. TRON (TRX) traded down 2.2% against the dollar and now trades at $0.0368 or 0.00000560 BTC. Binance Coin (BNB) traded down 1.9% against the dollar and now trades at $13.48 or 0.00205246 BTC. VeChain (VET) traded 1.5% higher against the dollar and now trades at $2.53 or 0.00038495 BTC. Ontology (ONT) traded 3.7% lower against the dollar and now trades at $4.78 or 0.00072703 BTC. Zilliqa (ZIL) traded 1.6% higher against the dollar and now trades at $0.0851 or 0.00001295 BTC.

IOST Token Profile

IOST’s launch date was January 20th, 2018. IOST’s total supply is 21,000,000,000 tokens and its circulating supply is 8,400,000,000 tokens. IOST’s official Twitter account is @IOStoken. The Reddit community for IOST is /r/IOStoken. IOST’s official website is iost.io. The official message board for IOST is medium.com/@iostoken.

IOST Token Trading

IOST can be purchased on these cryptocurrency exchanges: Kucoin, DDEX, Lykke Exchange, OTCBTC, Huobi, Koinex, IDEX, Hotbit, fex, Binance, Kyber Network, Cobinhood, OKEx, BigONE and Ethfinex. It is usually not presently possible to purchase alternative cryptocurrencies such as IOST directly using US dollars. Investors seeking to acquire IOST should first purchase Bitcoin or Ethereum using an exchange that deals in US dollars such as Coinbase, GDAX or Gemini. Investors can then use their newly-acquired Bitcoin or Ethereum to purchase IOST using one of the exchanges listed above.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “IOSTUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Harley-Davidson Ships Production Overseas as a Trade War Looms

The last thing Harley-Davidson (NYSE:HOG) needs are policies that will increase the cost of its already-expensive motorcycles, but President Trump's decision to impose tariffs on foreign aluminum and steel is having just that effect.

As promised, the European Union is slapping retaliatory tariffs on Harley motorcycles, as well as other products including bourbon, peanut butter, and orange juice. The only winners in such trade disputes are industries that use protectionism to limit competition. The burden always seems to fall on ancillary industries and businesses. This time, Harley is one of the victims.

Harley-Davidson is moving some motorcycle production overseas to sidestep EU tariffs. Image source: Getty Images.

Europe is key

The motorcycle king is in a spin. Sales in the U.S. (its largest market) are diving, so it is trying to raise international sales to the same level as domestic sales. And though sales overseas rose only 0.2% in the first quarter, that was decidedly better than the 12% decline in the U.S.

Europe is Harley's second-largest market behind the U.S., with almost 40,000 motorcycles sold there last year: about the same amount as in 2016. Tariffs that make its bikes more expensive won't make them an easier sell. So to compensate, Harley-Davidson is moving some production for the European market out of the U.S.

In a Securities and Exchange Commission filing last week, the bike maker said that with tariffs on its motorcycles jumping from 6% to 31%, the cost of each motorcycle it exported to the EU would rise by about $2,200, a price increase that, if actually imposed, would crush sales. So Harley said it won't be raising its prices, but instead will bear the cost of the tariffs, which will cost it $30 million to $45 million this year, or an annualized $90 million to $100 million.

As a result, Harley-Davidson will begin shifting production for the EU market to its international facilities. The company currently has plants in Brazil, India, and Australia, and it will soon open a new assembly plant in Thailand. Harley says the shift could take at least nine to 18 months to complete. It didn't detail what impact, if any, this would have on American jobs.

Be careful what you wish for

The irony is that Harley pushed for tariffs against imported motorcycles in the 1980s when it was trying to save itself from years of mismanagement. Now, it's being hoisted by its own petard.

Shares of Harley-Davidson, which were already depressed, fell sharply on the news of the latest�production shift and are down 18% for the year compared to a 2% gain for the S&P 500. There are still more hurdles ahead for the motorcycle maker.

Because of the poor optics of the iconic manufacturer moving production overseas, Trump threatened the company with onerous taxes, tweeting:

A Harley-Davidson should never be built in another country! ... If they move, watch, it will be the beginning of the end - they surrendered, they quit! The Aura will be gone and they will be taxed like never before!

Harley-Davidson is in a difficult position. Sales are falling, and it has had to cut jobs and consolidate production. And it now faces dramatically higher costs due to factors beyond its control.

The bike maker does have the benefit of being able to sidestep the EU tariffs -- eventually -- because it is a global company and can shift production elsewhere. However, because Trump has raised the cost of aluminum and steel, it is still caught in a bind: If it raises prices at home to compensate for the higher raw materials costs, it might experience even fewer sales; if it absorbs the costs as it's doing for the tariffs in Europe, it will hit profits. �

Harley-Davidson's problems are only noteworthy because it is a high-profile company. The impact on smaller businesses could be as large or even greater. There are few winners in trade wars and such battles leave a lot of collateral damage on all sides.